Cohen Richard M insider trades
Cohen Richard M has filed 23 Form 4s with the SEC that we hold, for Ondas Inc. (ONDS) (Director), Great Elm Capital Corp. (GECC) (Director), SMFL (Director) and 20/20 Biolabs, Inc. (AIDX) (Director). Across all of them we count 9 purchases worth $224.7K and 16 sales worth $417.0K reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($329.3K). The largest single trade was a sale of 7,500 shares of Ondas Inc. worth $71.2K, dated 2026-05-20. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-21 and the latest 2026-08-20.
Ondas Inc. (ONDS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-19 | S, sale reported on Form 4 | 3,509 | $6.4K | 2022-12-20 |
| 2023-08-17 | S, sale reported on Form 4 | 5,676 | $6.0K | 2023-08-21 |
| 2023-11-22 | S, sale reported on Form 4 | 5,930 | $6.4K | 2023-11-24 |
| 2024-06-05 | S, sale reported on Form 4 | 14,559 | $9.3K | 2024-06-07 |
| 2024-06-07 | S, sale reported on Form 4 | 14,953 | $8.8K | 2024-06-07 |
| 2024-12-19 | S, sale reported on Form 4 | 13,789 | $17.8K | 2024-12-20 |
| 2024-12-19 | S, sale reported on Form 4 | 11,517 | $14.9K | 2024-12-20 |
| 2025-03-21 | S, sale reported on Form 4 | 7,717 | $5.2K | 2025-03-21 |
| 2025-06-17 | S, sale reported on Form 4 | 7,567 | $12.8K | 2025-06-18 |
| 2025-12-22 | S, sale reported on Form 4 | 824 | $7.8K | 2025-12-23 |
| 2025-12-22 | S, sale reported on Form 4 | 457 | $4.3K | 2025-12-23 |
| 2025-12-22 | S, sale reported on Form 4 | 5,726 | $54.3K | 2025-12-23 |
| 2025-12-22 | S, sale reported on Form 4 | 6,985 | $66.2K | 2025-12-23 |
| 2025-12-22 | S, sale reported on Form 4 | 6,143 | $58.2K | 2025-12-23 |
| 2026-05-20 | S, sale reported on Form 4 | 7,500 | $71.2K | 2026-05-21 |
| 2026-08-18 | S, sale reported on Form 4 | 7,500 | $67.2K | 2026-08-20 |
Great Elm Capital Corp. (GECC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-15 | P, purchase reported on Form 4 | 2,612 | $24.7K | 2023-08-16 |
| 2025-06-06 | P, purchase reported on Form 4 | 1,000 | $10.6K | 2025-06-11 |
| 2025-06-06 | P, purchase reported on Form 4 | 1,500 | $16.1K | 2025-06-11 |
| 2025-06-09 | P, purchase reported on Form 4 | 2,500 | $27.8K | 2025-06-11 |
| 2025-06-09 | P, purchase reported on Form 4 | 1,500 | $16.2K | 2025-06-11 |
| 2025-06-10 | P, purchase reported on Form 4 | 3,500 | $39.0K | 2025-06-11 |
| 2025-06-11 | P, purchase reported on Form 4 | 5,000 | $55.9K | 2025-06-12 |
| 2025-06-12 | P, purchase reported on Form 4 | 3,100 | $33.9K | 2025-06-12 |
| 2025-06-13 | P, purchase reported on Form 4 | 36 | $396 | 2025-06-13 |
SMFL
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
20/20 Biolabs, Inc. (AIDX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1075891) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms